within Pharmacolibrary.Drugs.V_Various.V09I_TumourDetection.V09IX16_Piflufolastat18f;
model Piflufolastat18f 
   extends Pharmacolibrary.Drugs.ATC.V.V09IX16;

  annotation(Documentation(
    info ="<html><body><p>Piflufolastat (18F), also known as 18F-DCFPyL, is a radioactive diagnostic agent indicated for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. It is FDA-approved for use in prostate cancer patients with suspected metastasis or recurrence.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated from published clinical characteristics, predominantly in adult male prostate cancer patients, after intravenous administration.</p><h4>References</h4><ol><li><p>Kiess, AP, Minn, I, Chen, Y, Hobbs, R, Sgouros, G, Mease, RC, Pullambhatla, M, Shen, CJ, Foss, CA, &amp; Pomper, MG (2015). Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen. <i>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</i> 56(9) 1401–1407. DOI:<a href=&quot;https://doi.org/10.2967/jnumed.115.155929&quot;>10.2967/jnumed.115.155929</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26182968/&quot;>https://pubmed.ncbi.nlm.nih.gov/26182968</a></p></li><li><p>Plyku, D, Mena, E, Rowe, SP, Lodge, MA, Szabo, Z, Cho, SY, Pomper, MG, Sgouros, G, &amp; Hobbs, RF (2018). Combined model-based and patient-specific dosimetry for . <i>European journal of nuclear medicine and molecular imaging</i> 45(6) 989–998. DOI:<a href=&quot;https://doi.org/10.1007/s00259-018-3939-x&quot;>10.1007/s00259-018-3939-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29460025/&quot;>https://pubmed.ncbi.nlm.nih.gov/29460025</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end Piflufolastat18f;
